简体中文 | 繁體中文 | English

Health and Pharmaceutical Press Releases

2021-05-10 13:24 Aerobiotix Raises $25M Growth Equity Financing Led by Global Healthcare Investment Firm Vivo Capital
2021-05-10 09:46 FedEx Delivering Critical COVID-19 Aid to India
2021-05-08 17:30 Nearly 50% of Pandemic Costs Will Fall on Advanced Economies, World Government Summit Report Finds
2021-05-07 15:34 Aptorum Group Enters into an Agreement with Exeltis to Develop Aptorum’s Novel Preclinical Candidate Targeting Woman’s Gynecological Conditions
2021-05-07 14:43 SEASUN BIOMATERIALS Supplies On-site COVID-19 Rapid Molecular Diagnostic System to Seoul National University Campus
2021-05-07 13:28 First US Ischemic Stroke Patients Treated with Rapid Medical’s Novel Clot Retriever
2021-05-07 10:02 93rd Vifor Pharma Group Annual General Meeting
2021-05-07 09:46 Western Union Supports India COVID Relief
2021-05-07 09:39 CrownBio Acquires OcellO B.V. to Expand Its Preclinical In Vitro Drug Development Service Offerings
2021-05-06 17:30 Smiths Medical and Ivenix Partner to Revolutionize Infusion Management with First-Ever Comprehensive Suite of Infusion Solutions in US Healthcare Market
2021-05-06 14:57 Study Investigates the Ability of Masimo PVi® to Predict Preload Responsiveness in Patients On Nasal High-Flow Therapy
2021-05-06 10:18 Exscientia Announces Investment of up to $525M
2021-05-06 10:15 Treadwell Announces Initiation of Patient Dosing in TWT-202, a Phase 1b/2 study of PLK4 Inhibitor, CFI-400945, in Patients with Leukemia
2021-04-30 16:50 Takeda Manufacturing Facilities in Japan and Ireland Recognized With Category Awards for 2021 Facilities of the Year
2021-04-30 14:37 VFMCRP announces positive results of phase-III clinical trial of Velphoro® in China
2021-04-29 14:17 Vifor Pharma and Angion announce completion of enrollment in phase-II study of ANG-3777 for cardiac-surgery associated acute kidney injury
2021-04-29 09:52 Ultivue Announces $50M Financing Round
2021-04-29 09:10 Takeda Announces U.S. FDA Grants Priority Review for New Drug Application for Mobocertinib (TAK-788) as a Treatment for EGFR Exon20 Insertion+ Metastatic Non-Small Cell Lung Cancer
2021-04-28 17:33 Siemens Releases gPROMS FormulatedProducts 2.0 – New Application Areas and Key Usability Enhancements
2021-04-28 17:29 Clinical Data Shows Noxopharm’s Veyonda® May Prevent Cytokine Storm